ACADIA Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ACAD ACADIA Pharmaceuticals Inc
JLS Nuveen Mortgage and Income Fund
JNJ Johnson & Johnson
QIAN Qiansui International Group Co Ltd
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous system disorders. The Company's lead product, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA’s developments are focused on pimavanserin for additional neuropsychiatric conditions, trofinetide for Rett syndrome, ACP-044 for pain management and an early-stage muscarinic receptor program.

Closing Price
$27.42
Day's Change
0.12 (0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
27.60
Day's Low
26.91
Volume
(Light)
Volume:
1,201,621

10-day average volume:
1,649,987
1,201,621

Display:

Providers:

UpdateCancel
6 providers
Today's News, June 13, 2021
ACAD 5-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Before June 18th Application Deadline in Securities Class Action

San Francisco, California--(Newsfile Corp. - June 13, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff...(Newsfile)

CLASS ACTION UPDATE for ACAD, EBS and ATER: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...(Accesswire)

Yesterday's News, June 12, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD

New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company")(NASDAQ: ACAD) and certain of its officers. The class action...(Newsfile)

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with LARGE LOSSES to Secure Counsel Before Important June 18 Deadline in Securities Class Action - ACAD

NEW YORK, NY / ACCESSWIRE / June 12, 2021 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) between June...(Accesswire)

ACAD 6-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, Deadline Approaching in Securities Class Action

Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021 Lead Plaintiff Deadline: June 18, 2021 (Globe Newswire)

June 11, 2021
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of investors...(BusinessWire)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and DNMR

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have...(Accesswire)

FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 11, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ('Acadia' or 'the Company') for...(Accesswire)

SHAREHOLDER ALERT: ACAD EBS PCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to...(Accesswire)

CLASS ACTION UPDATE for ACAD, EBS and SPCE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...(Accesswire)

ACAD BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action - ACAD

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021, inclusive (the "Class Period") of the important June 18, 2021 lead...(BusinessWire)

FUV, ACAD & EBS Approaching Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Plaintiff Deadlines: June 18, 2021

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the...(Accesswire)

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - June 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ("Acadia" or "the...(Newsfile)

ACAD 7-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now, June 18th Application Deadline Approaching

SAN FRANCISCO, CA / ACCESSWIRE / June 11, 2021 / Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021 (Accesswire)

June 10, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD

Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company")(NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the...(PR Newswire)

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 18, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ...(Globe Newswire)

ACAD 8-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm

San Francisco, California--(Newsfile Corp. - June 10, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff...(Newsfile)

FUV, ACAD & EBS Last Few Days to Actively Participate: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Plaintiff Deadlines: June 18, 2021

NEW YORK, NY / ACCESSWIRE / June 10, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the...(Accesswire)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - June 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ...(Newsfile)

June 09, 2021
LAWSUITS FILED AGAINST CAN, ACAD and PCT - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / June 9, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed...(Accesswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.